Cambrian Biopharma vs Vandria

Distributed 'PipeCo' building a portfolio of therapeutics that target the biological drivers of aging to extend healthspan.

Clinical-stage Swiss biotech developing small-molecule mitophagy inducers to treat age-related and chronic diseases.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →